1. Introduction
In 2015, the World Health Organization World Report on Aging and Health emphasized the pressing need for strategies promoting healthy aging. It specifically underscored the importance of giving more significant focus to skin health as a means of maintaining overall well-being across the entire lifespan [
1]. Skin aging is induced and sustained by chronological aging and photoaging, and is clinically characterized by pigmentation, atrophy, a loss of elasticity, and an impaired recovery response against damage, resulting in subsequent pathologic skin disorders [
2]. For instance, cutaneous infections are common among the elderly due to a reduction in the skin’s barrier function and its immune defenses. Additionally, impaired wound healing further escalates the risk of infection. It is also widely recognized that senescent cells accumulate in the skin during aging, and even though they can’t proliferate, they continue to be metabolically active. These cells display an altered secretory profile, known as a senescence-associated secretory phenotype (SASP), which includes proinflammatory cytokines that significantly modify the skin’s microenvironment and contribute to inflammaging [
2]. More recently, skin pigmentation during the aging process has been actively discussed, and cellular senescence is thought to be a key player in skin-aging pigmentation [
3]. With the rise in life expectancy and a growing demand for solutions to reduce the signs of aging skin, there is a heightened interest in this research field, particularly with a focus on natural cosmetic products taking the spotlight [
4].
The significance of natural products is further fueled by consumers’ increasing preference for more environmentally friendly and ecologically conscious products [
5]. Furthermore, the research in cosmetics aims not only to improve skin appearance during aging but also to improve the quality of life of individuals by preventing or treating skin-related diseases [
4]. In this context, the term “cosmeceutical” has been coined, as is defined as a cosmetic product that include active ingredients with drug-like benefits [
5]. Natural products, including plants and their metabolites, have been used as skin care products for millennia, and modern formulations are causing their relevance to reemerge. Plants extracts are of particular interest since they are able to accomplish two tasks at once: skin care and source of nutrients required for the maintenance of skin functions, thus maintaining a healthy skin [
5]. This dual function is probably due to their phytochemicals, such as terpenoids, polyphenols, essential oils, vitamins, that altogether exert a plethora of functions such as antioxidant, tyrosinase inhibition, antimicrobial, anti-inflammatory and UV radiation protection, thus mitigating several hallmarks of skin aging [
4,
5].
The genus
Ferulago W. D. J. Koch is comprised of 48 subordinated taxa [
6], that are predominantly found in mild climate zones, such as Europe, Southwest and Middle Asia, the Caucasus and North Africa. Although in the Iberian Peninsula, this genus is represented by 4 species (
F. galbanifera (Mill.) W. D. J. Koch;
F. brachyloba Boiss. & Reut.;
F. lutea (Poir.) Grande and
F. granatensis Boiss.) [
7], in Portugal only the endemic species
F. lutea (
Ferulago capillaris (Link ex Spreng.) Cout.) is found [
8]. Plants from this genus are widely used in traditional medicines as antiseptic, for wound healing, for bronchitis and immunostimulant [
7]. As reviewed elsewhere, the biological properties of plants belonging to the
Ferulago genus have been thoroughly investigated. Nonetheless, when comparing
F. lutea to other species, studies on this particular plant are notably scarce. [
7]. For instance, the antifungal and antibacterial potential of the essential oil from the flowers [
9] and roots [
10] from
Ferulago lutea growing in Tunisia was previously reported. The Algerian
F. lutea also presents strong antimicrobial activity [
11]. The essential oil from the aerial parts of
Ferulago capillaris (=syn
F. lutea) growing in Portugal also displays strong antifungal properties against several pathogenic yeasts and filamentous fungi [
8]. In addition, several studies have shown that
F. lutea exerts anti-acetylcholinesterase activity [
9,
10] and antioxidant properties [
11]. The documented effects of
F. lutea underscore its potential for further utilization in the context of dermocosmetics and the development of skincare formulations.
Having this in mind, the present work aims to explore the protective role of Ferulago lutea essential oil collected in Portugal against skin aging hallmarks, particularly inflammation, impaired wound healing, pigmentation, and senescence. For the best knowledge of the authors, the selected bioactivities were never explored for this species. Our findings reveal that the essential oil extracted from F. lutea plants in Portugal exhibits several noteworthy properties. It demonstrates anti-inflammatory effects through the modulation of the NF-κB pathway, supports wound healing, has anti-lipogenic properties, and exhibits depigmenting capabilities. Additionally, our research indicates that the essential oil possesses anti-senescence properties, as it prevents the nuclear accumulation of γ-H2AX and regulates the p53/p21 signaling pathway.
3. Discussion
The current study underscores the positive effect of
F. lutea essential oil on skin aging hallmarks. We have demonstrated that this essential oil possesses anti-inflammatory properties, supports wound healing, reduces lipogenesis, exhibits depigmenting abilities and displays anti-senescent properties. Furthermore, our results demonstrated that the chemical composition of
F. lutea from Portugal is consistent with earlier studies on this species [
8]. This underscores that the essential oil extracted from plants growing in Portugal is primarily characterized by the presence of α-pinene and limonene. Overall,
we suggest that
F. lutea essential oil constitutes a likely promising source for prioritizing molecules with anti-aging properties.
A pro-inflammatory cytokine production in the skin is often associated with the onset and progression of several skin disorders [
18]. Undoubtedly, the cutaneous immune response plays a critical role in the regulation of skin aging and the development of immune-mediated skin conditions, notably eczema, acne, atopic dermatitis, and psoriasis. [
19,
20]. Because of the adverse effects reported for the conventional therapies (glucocorticoids and immunosuppressants), research has focused on the development of new therapeutic alternatives [
21,
22]. Based on the reported findings, we propose that
F. lutea EO may hold promise in the management of inflammatory skin conditions. While specific studies regarding the anti-inflammatory potential of
F. lutea are still pending, it’s worth noting that one study showed that
F. campestris, which is rich in myrcene, α-pinene, and γ-terpinene, reduced mRNA levels of IL-1β, IL-6, and iNOS. [
23]. The anti-inflammatory effect might be attributed to the high amounts of α-pinene and limonene. Indeed, a study has shown that both major compounds from
F. lutea exhibit anti-inflammatory effects in an acute model of pancreatitis [
24]. Other studies also demonstrated the anti-inflammatory potential of limonene [
25,
26] and α-pinene [
27,
28,
29] thereby confirming their roles in the activity of
F. lutea essential oil.
Skin aging often leads to impaired wound healing due to the prolongation of the inflammatory phase in the wound healing process [
30], thus contributing to the emergence of chronic wounds [
13]. Considering that the essential oil from
F. lutea exerts anti-inflammatory properties, we then hypothesize that it could also contribute beneficially to the wound healing process. Indeed, our results show that the essential oil promotes wound healing in a dose-dependent manner. Regarding studies with plants from the genus
Ferulago, no studies have been conducted as far; however, some studies have shown that the major compounds from the essential oil reported herein have wound healing potential. For instance, α-pinene have been shown to promote the formation of stress-resistant scars and wound contractions by eliciting collagen deposition [
31]. Other studies have also demonstrated wound healing properties for limonene [
32,
33,
34], including in a diabetic animal model, where a decrease in the pro-inflammatory environment was also observed [
33], similarly to our present study, thus suggesting that limonene might be the biggest contributor to the wound healing promotion capability of
F. lutea growing in Portugal.
During skin aging, sebaceous cells in the skin lose their functionality leading to a decrease in surface lipid levels and xerosis [
35]. In opposition, acne vulgaris promotes the production of sebum by activation of the enzyme acetyl-CoA carboxylase (ACC) [
15]. Our findings indicate that
F. lutea essential oil may offer advantageous outcomes in mitigating the decline in lipogenic capabilities associated with aging skin. Additionally, when applied in conditions characterized by elevated lipogenesis, such as acne vulgaris, it could potentially alleviate excessive sebum production. To the best of the authors’ knowledge, there is a lack of studies conducted on the impact of other
Ferulago species on lipogenesis.
Regarding isolated compounds, only limonene has been explored in lipogenesis. A study demonstrated that limonene exhibited a dual effect on 3T3-L1 adipocytes. On one hand, it increased lipid accumulation in adipocytes by activating the PPARγ, C/EBP-α, and C/EBP-β pathways. On the other hand, at higher doses, it had an opposing effect by reducing lipid accumulation [
36]. In another study, limonene was able to modulate AMPK-mediated expression of mRNA genes related to adipogenesis (PPARγ, C/EBPα, FABP4), and lipogenesis (SREBP-1c, ACC, FAS) [
37]. Having these results in mind, we suggest that limonene might be the major contributor to the anti-lipogenic effects reported herein for
F. lutea essential oil.
Although the number of melanocytes decrease, abnormal pigmentation is a common symptom accompanying aging skin. Furthermore, chronic UV exposure also leads to loss of function in fibroblasts, that help in the regulation of melanogenesis [
38]. Indeed, the crosstalk between melanocytes as pigmentary cells and other adjacent types of aged skin cells such as senescent fibroblasts play a role in skin-aging pigmentation. Our results show that the presence of
F. lutea essential oils decreases melanin, probably due to the inhibitory effect on tyrosinase, a key player in melanin production [
39]. Our study is the first addressing the depigmenting properties of extracts obtained from plants from the genus
Ferulago. Regarding isolated compounds, few studies have been conducted using limonene or α-pinene. Limonene was shown to protect keratinocytes against UVB-induced photodamage and photoaging [
40]. In addition, this compound is part of the commercial product Garnier Dark Spot Corrector [
41], thus reinforcing its skin lightening properties.
It is known that senescent cells contribute to skin aging [
42,
43], thus leading to the emergence of aged skin-related pathologies. Indeed, it has been shown that fibroblasts exposed to UVB exhibit DNA damage and consequent cell cycle arrest, in addition to the expression of senescence markers, particularly senescence associated β-galactosidase activity and p16, p21 and p53 activation [
42]. Importantly, senescent cells display an altered SASP, which includes proinflammatory cytokines. Our results show that
F. lutea essential oil reduces the activity of senescence-associated β-galactosidase, thus suggesting anti-senescence properties for this oil. The accumulation of γH2AX is a response to damaged DNA, that ultimately leads to cell cycle arrest and cellular senescence [
44]. Furthermore, as reviewed elsewhere [
45], double strand breaks only lead to cellular senescence, when they are resistant to repair processes, leading to a subset of γH2AX called persistent γH2AX. Having in mind that the essential oil decreases the accumulation of this marker, we hypothesize that it could prevent more serious damage to the DNA thus allowing its repair, which in turn prevent the activation of the p21/p53 axis for cell cycle arrest and consequent cellular senescence. Indeed, our results demonstrate that the essential oil is able to decrease the protein levels of both p53 and p21, thus reinforcing the anti-senescent potential of the essential oil. Our study highlights for the first-time anti-senescence properties for plants from the genus
Ferulago. The reported activity might be attributed to the presence of limonene and α-pinene. Indeed, limonene protects HaCaT cells from H
2O
2-induced aging [
46] and human keratinocytes from UVB-induced photoaging by activating Nrf2-dependent antioxidants [
40]. UVA-induced photoaging was also prevented by α-pinene by inhibition of matrix metalloproteinases expression [
47].
Overall, our study is the first to point out several properties to F. lutea essential oil that are relevant in the management of skin aging and associated pathologies. However, further studies need to be addressed in order to further validate these effects using more physiologically relevant models.
Figure 1.
Effect of F. lutea essential oil on cell viability. Cell viability was assessed using resazurin metabolization assay. Effect on RAW 264.7 (A), NIH/3T3 (B), B16V (C) and HaCaT (D) cell lines. Results show the mean ± SEM of at least three independent experiments performed in duplicate. *p<0.05, **p<0.01, ****p<0.0001, when compared to control (black bars) after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 1.
Effect of F. lutea essential oil on cell viability. Cell viability was assessed using resazurin metabolization assay. Effect on RAW 264.7 (A), NIH/3T3 (B), B16V (C) and HaCaT (D) cell lines. Results show the mean ± SEM of at least three independent experiments performed in duplicate. *p<0.05, **p<0.01, ****p<0.0001, when compared to control (black bars) after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 2.
Effect of F. lutea essential oil on LPS-stimulated macrophages. A) Nitric oxide production quantified as nitrites in the culture medium using the Griess reaction, after cells treatment with 0.64 µL/mL of the EO for 1h followed by stimulation with 50 ng/mL of LPS for 24h. ****p<0.0001, when compared to control; ###p<0.001; ####p<0.0001, when compared to LPS, after one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. B) Representative western blots for iNOS and pro-IL-1β. C) iNOS protein levels. D) Pro-IL-1β protein levels. Tubulin was used as loading control and values were normalized to LPS. Results represent mean ± SEM of at least three independent experiments. ****p<0.0001, when compared to control; ##p<0.01, when compared to LPS, after one-way ANOVA followed by Tukey’s multiple comparison test.
Figure 2.
Effect of F. lutea essential oil on LPS-stimulated macrophages. A) Nitric oxide production quantified as nitrites in the culture medium using the Griess reaction, after cells treatment with 0.64 µL/mL of the EO for 1h followed by stimulation with 50 ng/mL of LPS for 24h. ****p<0.0001, when compared to control; ###p<0.001; ####p<0.0001, when compared to LPS, after one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. B) Representative western blots for iNOS and pro-IL-1β. C) iNOS protein levels. D) Pro-IL-1β protein levels. Tubulin was used as loading control and values were normalized to LPS. Results represent mean ± SEM of at least three independent experiments. ****p<0.0001, when compared to control; ##p<0.01, when compared to LPS, after one-way ANOVA followed by Tukey’s multiple comparison test.
Figure 3.
The essential oil from F. lutea promotes cell migration. A) Representative bright-field images of NIH/3T3 fibroblasts 0h and 18h after scratch in the absence (Control) or presence of increasing doses of the essential oil (032 – 0.08 µL/mL). B) Percentage of closed wound determined using an ImageJ/FIJI plugin. Results represent mean ± SEM of at least three independent assays made in duplicate. *p<0.05 when compared to control after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 3.
The essential oil from F. lutea promotes cell migration. A) Representative bright-field images of NIH/3T3 fibroblasts 0h and 18h after scratch in the absence (Control) or presence of increasing doses of the essential oil (032 – 0.08 µL/mL). B) Percentage of closed wound determined using an ImageJ/FIJI plugin. Results represent mean ± SEM of at least three independent assays made in duplicate. *p<0.05 when compared to control after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 4.
F. lutea essential oil modulates lipogenesis in HaCaT keratinocytes. A) Representative bright-field images of HaCaT pre-treated with 0.32 µL/mL of F. lutea essential oil followed by 24h in the presence of T0901317 and then neutral lipids were stained with Oil Red O staining. B) Neutral lipid content in HaCaT keratinocytes quantified using ImageJ/FIJI. C) Neutral lipid content in HaCaT keratinocytes after Oil Red O stain solubilization in isopropanol and absorbance read at 500 nm. A minimum of 5 images were quantified in each replicate. Results shown as mean ± SEM of at least three independent experiments made in duplicate, ***p<0.001, ****p<0.0001 when compared to control, #p<0.05, ###p<0.001 when compared to T0901317 after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 4.
F. lutea essential oil modulates lipogenesis in HaCaT keratinocytes. A) Representative bright-field images of HaCaT pre-treated with 0.32 µL/mL of F. lutea essential oil followed by 24h in the presence of T0901317 and then neutral lipids were stained with Oil Red O staining. B) Neutral lipid content in HaCaT keratinocytes quantified using ImageJ/FIJI. C) Neutral lipid content in HaCaT keratinocytes after Oil Red O stain solubilization in isopropanol and absorbance read at 500 nm. A minimum of 5 images were quantified in each replicate. Results shown as mean ± SEM of at least three independent experiments made in duplicate, ***p<0.001, ****p<0.0001 when compared to control, #p<0.05, ###p<0.001 when compared to T0901317 after one-way ANOVA followed by Tukey’s multiple comparisons test.
Figure 5.
F. lutea essential oil exerts depigmenting effect on B16V melanocytes. A) Melanin content in B16V melanocytes after 48h of cells treatment with 3-isobutyl-1-methylxantine (IBMX) in the absence or presence of 0.32 µL/mL of F. lutea essential oil. B) Tyrosinase activity in B16V melanocytes after 48h of cells treatment with 3-isobutyl-1-methylxantine (IBMX) in the absence or presence of 0.32 µL/mL of F. lutea essential oil. Results show mean ± SEM of at least three independent experiments made in triplicate.*p<0.05 when compared to control, #p<0.05 when compared to IBMX after one-way ANOVA followed by Tukey’s multiple comparison test.
Figure 5.
F. lutea essential oil exerts depigmenting effect on B16V melanocytes. A) Melanin content in B16V melanocytes after 48h of cells treatment with 3-isobutyl-1-methylxantine (IBMX) in the absence or presence of 0.32 µL/mL of F. lutea essential oil. B) Tyrosinase activity in B16V melanocytes after 48h of cells treatment with 3-isobutyl-1-methylxantine (IBMX) in the absence or presence of 0.32 µL/mL of F. lutea essential oil. Results show mean ± SEM of at least three independent experiments made in triplicate.*p<0.05 when compared to control, #p<0.05 when compared to IBMX after one-way ANOVA followed by Tukey’s multiple comparison test.
Figure 6.
F. lutea essential oil decreases senescence-associated β-galactosidase activity. A) Representative bright-field images of NIH/3T3 fibroblasts treated for 24h with 12.5 µM Etoposide, followed by 24h in etoposide-free medium in the absence (black bar) or presence (gray bar) of 0.32 µL/mL of F. lutea essential oil. *p<0.05 when compared to Eto 12.5 µM, after Mann-Whitney test.
Figure 6.
F. lutea essential oil decreases senescence-associated β-galactosidase activity. A) Representative bright-field images of NIH/3T3 fibroblasts treated for 24h with 12.5 µM Etoposide, followed by 24h in etoposide-free medium in the absence (black bar) or presence (gray bar) of 0.32 µL/mL of F. lutea essential oil. *p<0.05 when compared to Eto 12.5 µM, after Mann-Whitney test.
Figure 7.
F. lutea essential oil decreases the nuclear accumulation of the phosphorylated form of H2AX (γ-H2AX). A) Representative confocal images of NIH/3T3 fibroblasts after 24h treatment with Etoposide (12.5 µM) followed by 24h in the presence of F. lutea essential oil (0.32 µL/mL). γH2AX was stained with Alexa Fluor 564 and nuclei were counterstained with DAPI. B) Mean fluorescence intensity (MFI) per nucleus quantified using threshold function in ImageJ/Fiji. A minimum of 6 images were used per condition in three independent assays. Results show the mean ± SEM of three independent assays. **** p<0.0001 when compared to control; #### p<0.0001 when compared to Eto.
Figure 7.
F. lutea essential oil decreases the nuclear accumulation of the phosphorylated form of H2AX (γ-H2AX). A) Representative confocal images of NIH/3T3 fibroblasts after 24h treatment with Etoposide (12.5 µM) followed by 24h in the presence of F. lutea essential oil (0.32 µL/mL). γH2AX was stained with Alexa Fluor 564 and nuclei were counterstained with DAPI. B) Mean fluorescence intensity (MFI) per nucleus quantified using threshold function in ImageJ/Fiji. A minimum of 6 images were used per condition in three independent assays. Results show the mean ± SEM of three independent assays. **** p<0.0001 when compared to control; #### p<0.0001 when compared to Eto.
Figure 8.
F. lutea essential oil modulates p53/p21 signaling pathway. A) Representative western blot of NIH/3T3 fibroblasts treated with etoposide 12.5 µM for 24h followed by an additional 24h in the absence (black bars) and presence (gray bars) of 0.32 µL/mL of F. lutea essential oil. B) Relative expression of p21 protein levels. C) Relative expression of p53 protein levels. Tubulin was used as loading control and values were normalized to etoposide. Results represent mean ± SEM of at least three independent assays. ****p<0.0001 when compared to control, #p<0.05 and ####p<0.0001 when compared to etoposide after one way ANOVA followed by Tukey’s multiple comparison tests.
Figure 8.
F. lutea essential oil modulates p53/p21 signaling pathway. A) Representative western blot of NIH/3T3 fibroblasts treated with etoposide 12.5 µM for 24h followed by an additional 24h in the absence (black bars) and presence (gray bars) of 0.32 µL/mL of F. lutea essential oil. B) Relative expression of p21 protein levels. C) Relative expression of p53 protein levels. Tubulin was used as loading control and values were normalized to etoposide. Results represent mean ± SEM of at least three independent assays. ****p<0.0001 when compared to control, #p<0.05 and ####p<0.0001 when compared to etoposide after one way ANOVA followed by Tukey’s multiple comparison tests.
Table 1.
Main compounds of the essential oil from Ferulago lutea.
Table 1.
Main compounds of the essential oil from Ferulago lutea.
Compounds * |
RI SPB-1a
|
RI SW 10b
|
% Peak area
|
α-Pinene |
930 |
1030 |
36.5 |
Camphene |
943 |
1077 |
1.5 |
Sabinene |
964 |
1128 |
0.5 |
β-Pinene |
970 |
1118 |
1.5 |
Myrcene |
980 |
1161 |
5.0 |
p-Cymene |
1009 |
1271 |
1.5 |
Limonene |
1020 |
1206 |
31.2 |
β-Phellandrene |
1020 |
1215 |
5.5 |
Z-β-Ocimene |
1025 |
1235 |
3.5 |
E-β-Ocimene |
1035 |
1253 |
1.0 |
γ-Terpinene |
1046 |
1249 |
0.5 |
Z-Linalool oxyde |
1055 |
1439 |
1.0 |
Terpinolene |
1076 |
1288 |
1.0 |
p-Cymenene-8-ol |
1160 |
1621 |
0.5 |
α-Copaene |
1364 |
1487 |
0.5 |
E-Caryophyllene |
1408 |
1590 |
0.5 |
Germacrene-D |
1466 |
1699 |
0.5 |
δ-Cadinene |
1508 |
1751 |
0.6 |
Total identified |
|
|
92.8 |